BALYASNY ASSET MANAGEMENT L.P. – Global Blood Therapeutics, Inc. Transaction History
BALYASNY ASSET MANAGEMENT L.P. portfolio value:
$51.07M
portfolio value
Global Blood Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 1.15M shares | 78.41M | $68.1 | 1.15M |
| Q3 2022 | call | Increase | 0.00% | 750K shares | 51.07M | $68.1 | 750K |
| Q1 2022 | share | Decrease | -100.00% | -104.15K shares | -3.04M | $34.64 | 0 |
| Q4 2021 | share | Increase | 0.00% | 104.15K shares | 3.04M | $29.86 | 104.15K |
| Q2 2019 | share | Decrease | -100.00% | -172.94K shares | -9.15M | $52.6 | 0 |
| Q2 2019 | call | Decrease | -100.00% | -315K shares | -16.67M | $52.6 | 0 |
| Q1 2019 | call | Increase | +75.00% | 135K shares | 9.28M | $52.93 | 315K |
| Q1 2019 | share | Decrease | -11.58% | -22.64K shares | 1.12M | $52.93 | 172.94K |
| Q4 2018 | share | Increase | +2862.63% | 188.99K shares | 7.77M | $41.05 | 195.59K |
| Q4 2018 | call | Increase | +373.68% | 142K shares | 5.83M | $41.05 | 180K |
| Q3 2018 | share | Decrease | -86.41% | -41.97K shares | -1.94M | $38 | 6.60K |
| Q3 2018 | call | Decrease | -11.63% | -5K shares | -392K | $38 | 38K |
| Q2 2018 | share | Decrease | -47.61% | -44.14K shares | -2.28M | $45.2 | 48.57K |
| Q2 2018 | call | Decrease | -65.60% | -82K shares | -4.09M | $45.2 | 43K |
| Q1 2018 | call | Increase | 0.00% | 125K shares | 6.03M | $48.3 | 125K |
| Q1 2018 | share | Increase | 0.00% | 92.72K shares | 4.47M | $48.3 | 92.72K |
| Q4 2017 | share | Decrease | -100.00% | -8.67K shares | -269K | $39.35 | 0 |
| Q3 2017 | share | Increase | 0.00% | 8.67K shares | 269K | $31.05 | 8.67K |
| Q2 2016 | share | Decrease | -100.00% | -30.3K shares | -481K | $16.59 | 0 |
| Q1 2016 | share | Increase | 0.00% | 30.3K shares | 481K | $15.86 | 30.3K |